KAYLA VOSS: Open Payments
NPI 1790403129 · FREDONIA, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$548 in 31 payments from 13 companies in 2025. Trend: 2023 $435 · 2024 $559 · 2025 $548
Food & beverage: $548
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 6 | $115 |
| AstraZeneca Pharmaceuticals LP | 6 | $115 |
| ABBVIE INC. | 3 | $56 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $52 |
| Sumitomo Pharma America, Inc. | 2 | $36 |
| Merck Sharp & Dohme LLC | 2 | $35 |
| Exact Sciences Corporation | 2 | $32 |
| PFIZER INC. | 2 | $28 |
| Lilly USA, LLC | 1 | $20 |
| Exeltis, USA Inc. | 1 | $18 |
Products named: FARXIGA, Wegovy, CAPLYTA, GEMTESA, AIRSUPRA, PREVNAR 20, VRAYLAR, GARDASIL 9.
Industry payments across NY — which companies pay providers there.
